Utility of Procalcitonin as an Early Diagnostic Marker of Bacteremia in Patients with Acute Fever
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Purpose: Procalcitonin (PCT) is a current, frequently used marker for severe bacterial infection. The aim of this study was to assess the ability of PCT levels to differentiate bacteremic from nonbacteremic patients with fever. We assessed whether PCT level could be used to accurately rule out a diagnosis of bacteremia. Materials and Methods: Serum samples and blood culture were obtained from patients with fever between August 2008 and April 2009. PCT was analyzed using a VIDAS^® B.R.A.H.M.S PCT assay. We reviewed the final diagnosis and patient histories, including clinical presentation and antibiotic treatment. Results: A total of 300 patients with fevers were enrolled in this study: 58 with bacteremia (positive blood culture) (group I); 137 with local infection (group II); 90 with other diseases (group III); and 15 with fevers of unknown origin (group IV). PCT levels were significantly higher in patients with bacteremia than in those with non-bacteremia (11.9 ± 25.1 and 2.5 ± 14.7 ng/mL, respectively, p < 0.001). The sensitivity and specificity were 74.2% and 70.1%, respectively, at a cut-off value of 0.5 ng/mL. A serum PCT level of < 0.4 ng/mL accurately rules out diagnosis of bacteremia. Conclusion: In febrile patients, elevated PCT may help predict bacteremia; furthermore, low PCT levels were helpful for ruling out bacteremia as a diagnosis. Therefore, PCT assessment could help physicians limit the number of prescriptions for antibiotics.
Abstract
Purpose: Procalcitonin (PCT) is a current, frequently used marker for severe bacterial infection. The aim of this study was to assess the ability of PCT levels to differentiate bacteremic from nonbacteremic patients with fever. We assessed whether PCT level could be used to accurately rule out a diagnosis of bacteremia. Materials and Methods: Serum samples and blood culture were obtained from patients with fever between August 2008 and April 2009. PCT was analyzed using a VIDAS^® B.R.A.H.M.S PCT assay. We reviewed the final diagnosis and patient histories, including clinical presentation and antibiotic treatment. Results: A total of 300 patients with fevers were enrolled in this study: 58 with bacteremia (positive blood culture) (group I); 137 with local infection (group II); 90 with other diseases (group III); and 15 with fevers of unknown origin (group IV). PCT levels were significantly higher in patients with bacteremia than in those with non-bacteremia (11.9 ± 25.1 and 2.5 ± 14.7 ng/mL, respectively, p < 0.001). The sensitivity and specificity were 74.2% and 70.1%, respectively, at a cut-off value of 0.5 ng/mL. A serum PCT level of < 0.4 ng/mL accurately rules out diagnosis of bacteremia. Conclusion: In febrile patients, elevated PCT may help predict bacteremia; furthermore, low PCT levels were helpful for ruling out bacteremia as a diagnosis. Therefore, PCT assessment could help physicians limit the number of prescriptions for antibiotics.
참고문헌 (21)
- Parrillo JE, "Pathogenetic mechanisms of septic shock", N Engl J Med, 328, pp.1471~1477 (1993)
- Mitaka C, "Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome", Clin Chim Acta, 351, pp.17~29 (2005)
- Reimer LG, "Update on detection of bacteremia and fungemia", Clin Microbiol Rev, 10, pp.444~465 (1997)
- Jacobs JW, "Procalcitonin is a glycoprotein", J Biol Chem, 256, pp.2803~2807 (1981)
- Reinhart K, "Procalcitonin as a marker of the systemic inflammatory response to infection", Intensive Care Med, 26, pp.1193~1200 (2000)
- Assicot M, "High serum procalcitonin concentrations in patients with sepsis and infection", Lancet, 341, pp.515~518 (1993)
- Brunkhorst FM, "Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock", Intensive Care Med, 26(Suppl 2), pp.S148~S152 (2000)
- Endo S, "Usefulness of procalcitonin serum level for the discrimination of severe sepsis from sepsis: a multicenter prospective study", J Infect Chemother, 14, pp.244~249 (2008)
- Harris KR, "Serum C-reactive protein. A useful and economical marker of immune activation in renal transplantation", Transplantation, 61, pp.1593~1600 (1996)
- Jongwutiwes U, "Serum procalcitonin in diagnosis of bacteremia", J Med Assoc Thai, 92(Suppl 2), pp.S79~S87 (2009)
- Luzzani A, "Comparison of procalcitonin and C-reactive protein as markers of sepsis", Crit Care Med, 31, pp.1737~1741 (2003)
- Chirouze C, "Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever", Clin Infect Dis, 35, pp.156~161 (2002)
- Rowther FB, "Prospective comparison of eubacterial PCR and measurement of procalcitonin levels with blood culture for diagnosing septicemia in intensive care unit patients", J Clin Microbiol, 47, pp.2964~2969 (2009)
- Bates DW, "Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group", J Infect Dis, 176, pp.1538~1551 (1997)
- Müller B, "Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit", Crit Care Med, 28, pp.977~983 (2000)
- Liaudat S, "Usefulness of procalcitonin serum level for the diagnosis of bacteremia", Eur J Clin Microbiol Infect Dis, 20, pp.524~527 (2001)
- Bossink AW, "Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-alpha1-antitrypsin, and lactoferrin compared with clinical variables", Clin Infect Dis, 29, pp.398~407 (1999)
- Charles PE, "Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria", BMC Infect Dis, 8, pp.38~ (2008)
- Becker KL, "Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations", Crit Care Med, 36, pp.941~952 (2008)
- 허미나, "혈액 배양 양성 패혈증 환자에서 프로칼시토닌과 C-반응성 단백의 진단 유용성 비교 분석", Annals of Laboratory Medicine, 29(6), pp.529~535 (2009), 대한진단검사의학회
- Schuttrumpf S, "Utility of procalcitonin concentration in the evaluation of patients with malignant diseases and elevated C-reactive protein plasma concentrations", Clin Infect Dis, 43, pp.468~473 (2006)